TY  - JOUR
AU  - Vaz-Luis, Ines
AU  - Masiero, Marianna
AU  - Cavaletti, Guido
AU  - Cervantes, Andres
AU  - Chlebowski, Rowan T
AU  - Curigliano, Giuseppe
AU  - Felip, Enriqueta
AU  - Ferreira, Arlindo R
AU  - Ganz, Patricia A
AU  - Hegarty, Josephine
AU  - Jeon, Justin
AU  - Johansen, Christoffer
AU  - Joly, Florence
AU  - Jordan, Karin
AU  - Koczwara, Bogda
AU  - Lagergren, Pernilla
AU  - Lambertini, Matteo
AU  - Lenihan, Daniel
AU  - Linardou, Helena
AU  - Loprinzi, Charles
AU  - Partridge, Ann H
AU  - Rauh, Stefan
AU  - Steindorf, Karen
AU  - van der Graaf, Winette
AU  - van de Poll-Franse, Lonneke
AU  - Pentheroudakis, George
AU  - Peters, Solange
AU  - Pravettoni, Gabriella
TI  - ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.
JO  - Annals of oncology
VL  - 33
IS  - 11
SN  - 0923-7534
CY  - Amsterdam [u.a.
PB  - Elsevier
M1  - DKFZ-2022-01794
SP  - 1119-1133
PY  - 2022
N1  - 2022 Nov;33(11):1119-1133
AB  - The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship.and methods: Herein, we reflected on the different components of survivorship care, existing models, and priorities, in order to facilitate the promotion of high-quality European survivorship care and research.We identified five main components of survivorship care: (1) physical effects of cancer and chronic medical conditions; (2) psychological effects of cancer; (3) social, work and financial effects of cancer (4) surveillance for recurrences and second cancers; and (5) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High quality care should be expedited by the generation of: (1) focused and shared European recommendations, (2) Creation of tools to facilitate implementation of coordinated care and (3) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers and patients and caregivers. The following patient centered survivorship research areas were highlighted: (1) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to a) understand the resources, needs and preferences of cancer patients, and b) understand biological determinants of survivorship issues, and (2) develop innovative effective interventions focused on the main components of survivorship care.ESMO can actively contribute in the efforts of the oncology community towards a) promoting the development of high-quality survivorship care programs, b) providing educational material and c) aiding groundbreaking research by reflecting on priorities and by supporting research networking.
LB  - PUB:(DE-HGF)16
C6  - pmid:35963481
DO  - DOI:10.1016/j.annonc.2022.07.1941
UR  - https://inrepo02.dkfz.de/record/181141
ER  -